Daniel M. Hartung

Also affiliated with Oregon State Hospital

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Decreasing Trends in Opioid Prescribing on Discharge to Hospice Care”.

Decreasing Trends in Opioid Prescribing on Discharge to Hospice Care

Journal of Pain and Symptom Management(2021)10.1016/j.jpainsymman.2021.03.025

N/A

0DataRank · unranked

11 citations

Brie N. Noble, Erik K. Fromme, Daniel M. Hartung, Jennifer Tjia, Mary R. Lynn +2 more

Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician

Journal of the American Pharmacists Association(2022)10.1016/j.japh.2022.12.001

N/A

0DataRank · unranked

13 citations

Jeffrey Bratberg, Zain Al-jammali, Jenny Arnold, Mary Gray, Anthony S. Floyd +5 more

Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study

Addiction Science & Clinical Practice(2022)10.1186/s13722-022-00318-1

N/A

0DataRank · unranked

11 citations

Sheila Markwardt, Kirbee Johnston, Jonah Geddes, Robin Baker, Gillian Leichtling +7 more

Readiness of community pharmacies to implement an opioid safety intervention

Journal of the American Pharmacists Association(2022)10.1016/j.japh.2022.10.031

N/A

0DataRank · unranked

10 citations

Joseph Silcox, Emma M. Cousin, Adriane N. Irwin, Mary Gray, Derek Bolivar +7 more

Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire

Journal of the American Pharmacists Association(2022)10.1016/j.japh.2022.10.012

N/A

0DataRank · unranked

2 citations

Daniel M. Hartung, Joseph Silcox, Jeffrey Bratberg, Jesse Boggis, Megan Rabin +2 more

“Like it was just everyday business”: A qualitative study of pharmacy-based naloxone and syringe customer experience

Journal of the American Pharmacists Association(2023)10.1016/j.japh.2023.01.013

N/A

0DataRank · unranked

13 citations

Sarah Shin, Joseph Silcox, Diana Flores, Derek Bolivar, Adriane N. Irwin +6 more

Outcomes After a Statewide Policy to Improve Evidence-Based Treatment of Back Pain Among Medicaid Enrollees in Oregon

Journal of General Internal Medicine(2024)10.1007/s11606-024-08776-w

N/A

0DataRank · unranked

2 citations

Christina J. Charlesworth, Catherine J. Livingston, Daniel M. Hartung, Sanae El Ibrahimi, Liliya Kraynov +2 more

Changes in Buprenorphine Prescribing in Community Health Centers

JAMA Health Forum(2024)10.1001/jamahealthforum.2024.0634

N/A

0DataRank · unranked

1 citations

Robert Voss, Steffani R. Bailey, Nathalie Huguet, John Muench, Daniel M. Hartung